Liberate Medical Secures $6.2M in Series B Financing

CRESTWOOD, Ky.–(BUSINESS WIRE)–Liberate Medical, an emerging leader in the development of novel non-invasive neurostimulation devices focused on transforming respiratory care, announced today the successful closure of its $6.2M Series B financing round. The funding was co-led by a large strategic investor and Scientific Health Development, who will both join Liberate…
Click here to view original post